论文部分内容阅读
30例膀胱癌患者术后定期应用吡柔比星(30mg/40ml)膀胱内灌注 ,并进行疗效观察,结果灌注化疗后1年内无肿瘤复发率93 3 % ,2年内无肿瘤复发率80 0 % ,未见有全身性药物不良反应。
Thirty patients with bladder cancer were treated with intravesical instillation of pirarubicin (30mg / 40ml) regularly after operation and the results were observed. The results showed that there was no recurrence rate of 93.3% within one year after chemotherapy and no tumor recurrence within 80% , No systemic adverse drug reactions.